Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(17 sites)
United States
University of Alabama at Birmingham (Children's of Alabama), Birmingham, Alabama Phoenix Children's Hospital, Phoenix, Arizona Connecticut Children's Medical Center, Hartford, Connecticut University of Florida, Gainesville, Florida Nemours Jacksonville, Jacksonville, Florida University of Miami, Miami, Florida Moffitt Cancer Center, Tampa, Florida University of Kentucky, Lexington, Kentucky Helen DeVos Children's Hospital, Grand Rapids, Michigan Roswell Park Comprehensive Cancer Center, Buffalo, New York Montefiore Medical Center, The Bronx, New York University of North Carolina, Chapel Hill, North Carolina Levine Cancer Institute, Charlotte, North Carolina Cleveland Clinic Children's, Cleveland, Ohio Nationwide Children's Hospital, Columbus, Ohio Vanderbilt University Medical Center, Nashville, Tennessee Primary Children's Hospital, Salt Lake City, Utah